OXFORD, Miss., July 05, 2023 (GLOBE NEWSWIRE) -- Oxford Treatment Center, a leading provider of substance use and co-occurring mental health treatment in Mississippi, is warning residents about the...
The Biden administration recently declared fentanyl laced with xylazine – an animal sedative commonly known as “tranq” – to be an emerging threat facing the United States, and a new analysis of toxicology reports illustrates its sharp rise.
IRWINDALE, Calif., June 2, 2023 /PRNewswire/ -- Xylazine is a non-opioid pharmaceutical drug used in veterinary medicine. It is not FDA-approved for use in humans. Almost exclusively found alongside opioids like fentanyl, xylazine has profoundly sedating effects that may be difficult to distinguish from those of opioids. Its exact mechanisms are not fully understood. Primary concerns of xylazine consumption include manual airway blockage due to sedation, which dramatically increases risks of opioid-related overdose, as well as poorly-healing wounds that may become necrotic.
‘Tranq,’ or Xylazine Can Worsen the Overdose Crisis Warns Laguna Treatment Hospital
Feb 28 (Reuters) - U.S. health regulators on Tuesday issued an import alert for drug ingredients and products related to Xylazine, used largely as a veterinary tranquilizer but has been a drug of abuse, to restrict its unlawful entry into the United States.
Health Canada Issues Recall of Dechra Veterinary Products Inc`s NERFASIN 20
Health Canada Recalls Dechra Veterinary Products` Nerfasin 2.0 (Xylazine Hydrochloride) due to presence of particles